Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026)

Opko Health (OPK) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $22.2 million the latest figure, recorded in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $22.2 million, down 5.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $90.3 million (up 25.81% YoY), and the FY2025 annual result was $91.6 million, down 6.67% from the prior year.
• Depreciation & Amortization (CF) was $22.2 million for Q1 2026 at Opko Health, down from $22.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $28.0 million in Q2 2022 and troughed at $22.2 million in Q1 2026.
• Average Depreciation & Amortization (CF) over 5 years is $25.2 million, with a median of $25.9 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) jumped 47.63% in 2022 and declined 9.04% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $26.5 million in 2022, then fell by 1.81% to $26.0 million in 2023, then slipped by 7.0% to $24.2 million in 2024, then dropped by 7.41% to $22.4 million in 2025, then declined by 0.77% to $22.2 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $22.2 million in Q1 2026, $22.4 million in Q4 2025, and $22.7 million in Q3 2025.